Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
This third European survey will identify risk factors in coronary patients, their blood relatives and high risk individuals, describe their management through lifestyle and use of drug therapies and provide an objective assessment of clinical implementation of current scientific knowledge.
This project is based on hospital patients with coronary heart disease, their blood relatives (if there is premature CHD) and for the first time apparently healthy individuals in primary care at high risk of developing cardiovascular disease.
To determine in hospitalised coronary patients (acute myocardial infarction and ischaemia and following revascularisation by angioplasty or coronary artery surgery) and in high risk individuals being treated in primary care whether the Joint European Guidelines on cardiovascular disease prevention are being followed.
To determine whether the practice of preventive cardiology in patients with established coronary disease in EUROASPIRE III has improved by comparison with those centres which took part in EUROASPIRE I and II.
To determine in the families (first degree blood relatives) of patients with premature CHD (men under 55 years and women under 65 years) whether screening for risk factors has occurred and, if so, to describe their management by lifestyle and drug therapies.
To determine whether the practice of preventive cardiology in first degree blood relatives of patients with premature CHD in EUROASPIRE III has improved by comparison with the results from EUROASPIRE II.
To follow up patients from EUROASPIRE I and II for total and cause-specific mortality to determine the relationships between risk factors measured at interview and event-free survival.
U. Keil (Chairman)
D. Wood (Principal Investigator)
G. De Backer, D. De Bacquer, G. B. Ambrosio, P. Amouyel, D. Cokkinos,
J. W. Deckers, V. Dzerve, Z. Fraz, D. Gaita, N. Gotcheva, I. Graham, K. Kotseva,
A. Laucevicius, S. Lehto, P. Nicolaides, R. Oganov, E. Östör, A. Pajak, K. Pyörälä,
Z. Reiner, J. Simon, L. Tokgözoğlu, J. De Velasco
© 2017 European Society of Cardiology. All rights reserved